Skip to main content
Erschienen in: Supportive Care in Cancer 10/2012

01.10.2012 | Original Article

Chore or priority? Barriers and facilitators affecting dilator use after pelvic radiotherapy for gynaecological cancer

verfasst von: Carissa Bonner, Kathryn Nattress, Caroline Anderson, Jonathan Carter, Chris Milross, Shannon Philp, Ilona Juraskova

Erschienen in: Supportive Care in Cancer | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Pelvic radiotherapy for gynaecological cancer often leads to damage of the vaginal mucosa, resulting in stenosis (obstruction by scar tissue). Stenosis has been associated with sexual dysfunction and can hinder medical examinations to detect recurrence. The use of vaginal dilators is frequently recommended to prevent or minimise stenosis, but women are reluctant to use these devices. The aim of this study was to explore the patient experience of dilator use and identify the barriers and facilitators affecting compliance with clinician recommendations.

Methods

Women were eligible for the study if they had undergone pelvic radiotherapy for gynaecological cancer up to 2 years ago and received a vaginal dilator as part of their post-treatment rehabilitation. Fifteen participants completed a semi-structured interview.

Results

Barriers to dilator use included: uncertainty about how/when to use dilators, viewing it as a negative experience, lack of time or forgetting and the need for discretion due to an association with sex aids. Facilitators included: concern about stenosis, belief that dilators work, reminders of stenosis, acceptance of dilator use as part of their normal routine or an extension of medical treatment and focusing on positive aspects. These factors were incorporated into a model of dilator use based on the Health Belief Model.

Conclusions

This is the first qualitative study to specifically investigate the patient experience of dilator use. The barriers and facilitators identified in this study and the proposed theory-based model provide new insights to inform future research and clinical management of dilator use.
Literatur
1.
Zurück zum Zitat Hartman P, Diddle AW (1972) Vaginal stenosis following irradiation therapy for carcinoma of the cervix uteri. Cancer 30:426–429PubMedCrossRef Hartman P, Diddle AW (1972) Vaginal stenosis following irradiation therapy for carcinoma of the cervix uteri. Cancer 30:426–429PubMedCrossRef
2.
Zurück zum Zitat Lancaster L (2004) Preventing vaginal stenosis after brachytherapy for gynaecological cancer: an overview of Australian practices. Eur J Oncol Nurs 8(1):30–39PubMedCrossRef Lancaster L (2004) Preventing vaginal stenosis after brachytherapy for gynaecological cancer: an overview of Australian practices. Eur J Oncol Nurs 8(1):30–39PubMedCrossRef
3.
Zurück zum Zitat Jeffries SA, Robinson JW, Craighead PS, Keats MR (2006) An effective group psychoeducational intervention for improving compliance with vaginal dilation: a randomized controlled trial. Int J Radiat Oncol Biol Phys 65(2):404–411PubMedCrossRef Jeffries SA, Robinson JW, Craighead PS, Keats MR (2006) An effective group psychoeducational intervention for improving compliance with vaginal dilation: a randomized controlled trial. Int J Radiat Oncol Biol Phys 65(2):404–411PubMedCrossRef
4.
Zurück zum Zitat Bruner DW, Lanciano R, Keegan M, Corn B, Martin E, Hanks GE (1993) Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial cancer. Int J Radiat Oncol Biol Phys 27(4):825–830PubMedCrossRef Bruner DW, Lanciano R, Keegan M, Corn B, Martin E, Hanks GE (1993) Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial cancer. Int J Radiat Oncol Biol Phys 27(4):825–830PubMedCrossRef
5.
Zurück zum Zitat Decruze SB, Guthrie D, Magnani R (1999) Prevention of vaginal stenosis in patients following vaginal brachytherapy. Clin Oncol 11:46–48CrossRef Decruze SB, Guthrie D, Magnani R (1999) Prevention of vaginal stenosis in patients following vaginal brachytherapy. Clin Oncol 11:46–48CrossRef
6.
Zurück zum Zitat Flay LD, Matthews JH (1995) The effects of radiotherapy and surgery on the sexual function of women treated for cervical cancer. Int J Radiat Oncol Biol Phys 31:399–404PubMedCrossRef Flay LD, Matthews JH (1995) The effects of radiotherapy and surgery on the sexual function of women treated for cervical cancer. Int J Radiat Oncol Biol Phys 31:399–404PubMedCrossRef
7.
Zurück zum Zitat Schover LR, Fife M, Gershenson DM (1989) Sexual dysfunction and treatment for early stage cervical cancer. Cancer 63(1):204–212PubMedCrossRef Schover LR, Fife M, Gershenson DM (1989) Sexual dysfunction and treatment for early stage cervical cancer. Cancer 63(1):204–212PubMedCrossRef
8.
Zurück zum Zitat Denton AS, Maher EJ (2003) Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy. Cochrane Database of Systematic Reviews, Issue 1 Denton AS, Maher EJ (2003) Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy. Cochrane Database of Systematic Reviews, Issue 1
9.
Zurück zum Zitat Miles T, Johnson N (2010) Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database of Systematic Reviews, Issue 9 Miles T, Johnson N (2010) Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database of Systematic Reviews, Issue 9
10.
Zurück zum Zitat White ID, Faithfull S (2006) Vaginal dilation associated with pelvic radiotherapy: a UK survey of current practice. Int J Gynecol Cancer 16:1140–1146PubMedCrossRef White ID, Faithfull S (2006) Vaginal dilation associated with pelvic radiotherapy: a UK survey of current practice. Int J Gynecol Cancer 16:1140–1146PubMedCrossRef
11.
Zurück zum Zitat Juraskova I, Butow P, Robertson R, Sharpe L, McLeod C, Hacker NF (2003) Post-treatment sexual adjustment following cervical and endometrial cancer: a qualitative insight. Psycho-Oncol 12:267–279CrossRef Juraskova I, Butow P, Robertson R, Sharpe L, McLeod C, Hacker NF (2003) Post-treatment sexual adjustment following cervical and endometrial cancer: a qualitative insight. Psycho-Oncol 12:267–279CrossRef
12.
Zurück zum Zitat Krumm S, Lamberti J (1993) Changes in sexual behaviour following radiation therapy for cervical cancer. J Psychosom Obstet Gynaecol 14(1):51–63PubMedCrossRef Krumm S, Lamberti J (1993) Changes in sexual behaviour following radiation therapy for cervical cancer. J Psychosom Obstet Gynaecol 14(1):51–63PubMedCrossRef
13.
Zurück zum Zitat Robinson JW, Faris PD, Scott CB (1999) Psychoeducational group increases vaginal dilation for younger women and reduces sexual fears for women of all ages with gynecological carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 44(3):497–506PubMedCrossRef Robinson JW, Faris PD, Scott CB (1999) Psychoeducational group increases vaginal dilation for younger women and reduces sexual fears for women of all ages with gynecological carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 44(3):497–506PubMedCrossRef
14.
Zurück zum Zitat Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370PubMedCrossRef Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370PubMedCrossRef
15.
Zurück zum Zitat Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3:77–101CrossRef Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3:77–101CrossRef
16.
Zurück zum Zitat Rosenstock I (1974) The Health Belief Model and preventive health behaviour. In: The Health Belief Model and personal health behaviour. M. Becker (ed). Thorofare: Charles B Slack. 27–59 Rosenstock I (1974) The Health Belief Model and preventive health behaviour. In: The Health Belief Model and personal health behaviour. M. Becker (ed). Thorofare: Charles B Slack. 27–59
17.
Metadaten
Titel
Chore or priority? Barriers and facilitators affecting dilator use after pelvic radiotherapy for gynaecological cancer
verfasst von
Carissa Bonner
Kathryn Nattress
Caroline Anderson
Jonathan Carter
Chris Milross
Shannon Philp
Ilona Juraskova
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 10/2012
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1337-z

Weitere Artikel der Ausgabe 10/2012

Supportive Care in Cancer 10/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.